Atyr PHARMA (ATYR) News Today $1.88 +0.13 (+7.43%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 6 at 6:23 AM | americanbankingnews.comAtyr PHARMA (NASDAQ:ATYR) Now Covered by Jefferies Financial GroupSeptember 4 at 2:03 AM | americanbankingnews.comAtyr PHARMA (ATYR) & Its Peers Critical ComparisonSeptember 3, 2024 | americanbankingnews.comCritical Comparison: Atyr PHARMA (ATYR) and Its CompetitorsSeptember 2, 2024 | americanbankingnews.comComparing Atyr PHARMA (ATYR) & Its CompetitorsSeptember 2, 2024 | americanbankingnews.comCritical Comparison: Atyr PHARMA (ATYR) versus Its PeersAugust 30, 2024 | marketbeat.comAtyr PHARMA INC (NASDAQ:ATYR) Sees Large Growth in Short InterestAtyr PHARMA INC (NASDAQ:ATYR - Get Free Report) saw a significant increase in short interest in August. As of August 15th, there was short interest totalling 346,800 shares, an increase of 28.2% from the July 31st total of 270,600 shares. Based on an average trading volume of 384,700 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.5% of the company's shares are short sold.August 30, 2024 | americanbankingnews.comReviewing Atyr PHARMA (NASDAQ:ATYR) & LianBio (NASDAQ:LIAN)August 21, 2024 | globenewswire.comaTyr Pharma to Participate in September Investor ConferencesAugust 18, 2024 | uk.finance.yahoo.comaTyr Pharma, Inc. (ATYR)August 17, 2024 | marketbeat.comAtyr PHARMA INC (NASDAQ:ATYR) Sees Large Decline in Short InterestAtyr PHARMA INC (NASDAQ:ATYR - Get Free Report) was the target of a large decline in short interest in July. As of July 31st, there was short interest totalling 270,600 shares, a decline of 19.6% from the July 15th total of 336,600 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average daily volume of 451,500 shares, the days-to-cover ratio is currently 0.6 days.August 16, 2024 | marketbeat.comQ3 2024 Earnings Estimate for Atyr PHARMA INC Issued By HC Wainwright (NASDAQ:ATYR)Atyr PHARMA INC (NASDAQ:ATYR - Free Report) - Research analysts at HC Wainwright increased their Q3 2024 earnings per share estimates for shares of Atyr PHARMA in a report released on Wednesday, August 14th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings peAugust 15, 2024 | finance.yahoo.comIs aTyr Pharma (NASDAQ:ATYR) In A Good Position To Invest In Growth?August 14, 2024 | marketbeat.comAtyr PHARMA (NASDAQ:ATYR) Given "Outperform" Rating at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and set a $16.00 price target on shares of Atyr PHARMA in a research note on Wednesday.August 14, 2024 | marketbeat.comAtyr PHARMA (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPSAtyr PHARMA (NASDAQ:ATYR - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.01.August 13, 2024 | globenewswire.comaTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate UpdateAugust 1, 2024 | marketbeat.comAtyr PHARMA (NASDAQ:ATYR) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $35.00 target price on shares of Atyr PHARMA in a research note on Thursday.August 1, 2024 | markets.businessinsider.comaTyr Pharma’s Strategic Advances in Clinical Research Bolster Buy RatingJuly 25, 2024 | insidertrades.comAtyr PHARMA INC (NASDAQ:ATYR) Director Purchases $100,939.00 in StockJuly 25, 2024 | insidertrades.comAtyr PHARMA INC (NASDAQ:ATYR) Director Paul Schimmel Purchases 41,052 Shares Get Atyr PHARMA News Delivered to You Automatically Sign up to receive the latest news and ratings for ATYR and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia’s New $1 Trillion SuperProject? (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. ATYR Media Mentions By Week ATYR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATYR News Sentiment▼0.150.55▲Average Medical News Sentiment ATYR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATYR Articles This Week▼63▲ATYR Articles Average Week Get Atyr PHARMA News Delivered to You Automatically Sign up to receive the latest news and ratings for ATYR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Terns Pharmaceuticals News Anavex Life Sciences News Verve Therapeutics News Sage Therapeutics News COMPASS Pathways News Contineum Therapeutics News Altimmune News Acelyrin News Neurogene News GH Research News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATYR) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atyr PHARMA INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Atyr PHARMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
